SEC Form 4 · accession 0001209191-16-136999
STERIS plc · STE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel A Carestio
Officer — Sr. V. P., Isomedix & Life Sci
Period of report
Aug 12, 2016
Accepted (ET)
Aug 15, 2016 · 4:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001624899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, 0.10 Nominal ValueF1,F2 | Aug 12, 2016 | S | 2,681 | $71.0387 | D | 17,800 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This represents the average sales price of the 2,681 shares sold in the open market. The actual sales prices ranged from $70.64 per share to $71.27 per share. Issuer, upon request by the SEC staff, will provide full information regarding the number of shares sold at each of these three sales prices.
- F217,800 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,300 on May 31, 2017; 4,000 on May 30, 2018, 5,000 on May 28, 2019, 3,000 on October 1, 2019 and 2,500 on June 1, 2020.